Rely on us for your high-quality sterile injectable manufacturing
Hikma provides extensive capabilities for manufacturing sterile injectable products, including vials (liquid and lyophilised), prefilled syringes, infusion bags, and ampoules for aqueous, oil-based, suspension, or emulsion forms.
With an installed capacity of over 500 million units, expansion is underway in both the EU and the US.
Excellent Quality RecordUS FDA | EMA | Japan FDA | Jordan FDA | Korea | GCC | ANVISA
Integrated servicesDevelopment phase | Scale-up processes | Fill and finish
Distribution50+ markets
Our operations
It is the global hub for the Injectables business. It includes: • Three segregated plants for the manufacturing of general formulation products, high containment products and cephalosporins antibiotics • Our capabilities cover different forms and technologies, including vials and ampoules, prefilled syringes, IV bags, emulsions/suspensions and oils • The site services, the US, EU, UK and MENA markets.
Our liquid and lyophilisation cytotoxic hub for the US, Europe and MENA.
Our lyophilisation hub for Europe and MENA.
It produces a variety of injectables products in various forms, including prefilled syringes.
Our newest site for septic bags filling and lyophilisation for the US.
High-quality prefilled manufacturing operations in the US
Get in touch
Contact us to discuss your injectable CMO needs and book a tour in our facilities.
